In a move that reflects the accelerating pace of innovation in the Egyptian pharmaceutical market, Elixir Pharma has announced the official launch of Enzymax, a new gastrointestinal health solution featuring Cap-in-Cap technology for the first time in Egypt. The announcement took place during the scientific conference “A Year in Review”, which has become one of the key platforms for discussing the latest advances in clinical practice and the pharmaceutical industry.

This launch is not just the introduction of another product to the market; it signals a real shift in the way dyspepsia and irritable bowel syndrome (IBS) are managed. Enzymax is built on advanced technology and carefully designed formulations that target both the stomach and intestines with high precision, addressing the needs of physicians, pharmacists and patients alike.

The burden of dyspepsia: a common complaint with real impact on quality of life

A large number of patients in Egypt suffer from dyspepsia symptoms after meals, particularly large or high-fat meals. These symptoms include a feeling of heaviness and fullness, abdominal cramps, bloating, gas, heartburn or acid regurgitation, in addition to fatigue and sluggishness after eating.

Dyspepsia is essentially difficulty or slowness in digesting food, which directly affects comfort, mood and the ability to carry out daily activities in a normal way.

With today’s fast-paced lifestyle and unbalanced dietary habits, the need for safe and effective solutions to manage dyspepsia has become urgent — a need that Elixir Pharma aims to address through the Enzymax range.

Enzymax Dual Release: a “smart” capsule for dyspepsia… relief in 20 minutes

Enzymax Dual Release stands out as one of the key innovations in the range, relying on Cap-in-Cap technology designed to work in two consecutive phases along the digestive tract:

• Outer capsule

  • Opens in the stomach and releases 5 digestive enzymes, initiating digestion early.

  • Helps reduce the feeling of heaviness after meals.

  • Provides patients with a sense of relief within just 20 minutes of taking the dose, making it particularly suitable for those who experience intense and distressing symptoms after eating.

• Inner capsule

  • Opens in the intestines and releases 7 additional digestive enzymes, intelligently completing the digestive process along the gastrointestinal tract.

  • Provides ongoing support for better nutrient absorption and helps reduce bloating, gas and digestive discomfort.

With this innovative combination of 8 digestive enzymes, Enzymax Dual Release becomes an advanced option for dyspepsia cases that require a comprehensive solution starting from the stomach and extending to the intestines. An added advantage is that the enzymes are derived from a safe and effective microbial source, while the product itself is imported from Spain and manufactured under strict pharmaceutical quality standards.

In terms of daily use, it is recommended to take:

• One to two capsules daily before the main meal in cases of dyspepsia, helping the digestive system prepare before large amounts of food are ingested.

Gut microbiota: the hidden key to digestive health

Digestive problems are not limited to dyspepsia alone; they often extend to deeper disorders linked to what is known as the gut microbiota – the billions of bacteria that live in our intestines, most of which are beneficial and play essential roles in:

• Improving the digestive process

• Producing certain important vitamins

• Supporting immunity and protecting against pathogens

When the microbiota is in balance, bowel movements are more regular, bloating is reduced, and mood is generally better. However, when an imbalance occurs – a state known as dysbiosis – patients may experience:

• Chronic bloating, gas and abdominal cramps

• Recurrent constipation, diarrhea or alternating between both

• Symptoms resembling irritable bowel syndrome (IBS), such as frequent abdominal pain, a sense of incomplete evacuation and worsening symptoms with stress

In such situations, the ideal solutions are those that do not focus solely on digestive enzymes, but also help restore the balance of beneficial bacteria in the gut.

Enzymax DuoBiotics: comprehensive support for IBS and microbiota balance

Enzymax DuoBiotics has been specifically designed for conditions related to microbiota disturbances, such as IBS and chronic bloating. The product is based on a symbiotic formula that combines:

• Inner capsule

  • Probiotic:

    • Contains 5 billion CFU of Lactobacillus plantarum, a strain with a significant role in restoring microbial balance and reducing IBS-related symptoms.

  • Prebiotic:

    • A component that nourishes beneficial bacteria and helps them grow and stabilize in the intestines.

• Outer capsule

  • Contains 5 additional digestive enzymes that enhance digestive efficiency and reduce the burden of undigested food, which can otherwise worsen bloating and gas.

Cap-in-Cap technology also ensures that the sensitive ingredients reach the colon in their active form, achieving:

• Restoration of beneficial bacterial balance in the colon

• Reduction of bloating, gas and cramps

• Improved digestive efficiency and reduced IBS symptoms

• A high-quality Spanish-made product

For practical use, the recommended dose in IBS cases is:

• One capsule daily with the main meal, ensuring the simultaneous delivery of appropriate doses of probiotics, prebiotics and digestive enzymes.

Cap-in-Cap technology: an advanced platform built around the patient

The Enzymax range is built on Cap-in-Cap technology, which has demonstrated its ability to:

• Protect sensitive ingredients from premature breakdown in the acidic environment of the stomach

• Ensure precise and targeted release of the active components at the desired site in the gastrointestinal tract (stomach or intestine)

• Combine more than one function or mechanism of action in a single dose, thereby reducing the number of capsules and improving patient adherence

• Deliver faster and more evident clinical results thanks to the intelligent distribution of ingredients across different stages of digestion

This technology not only elevates the scientific value of the products, but also enhances the real-life patient experience: patients feel tangible improvement within a reasonable time frame, with a simple and convenient dosing regimen.